Reach Surgical | Minimally Invasive Surgical Equipments

1st in China, 3rd in the World to Provide Comprehensive Minimally Invasive Surgical Solutions

Reach Surgical’s ENDO III Stapler Breaks Through Patent Barriers in Europe and the U.S.

Founded in Beijing in 2005 and settled in Tianjin Economic-Technological Development Area (TEDA) in 2009, Reach Surgical (Tianjin) Co., Ltd. is a technology-leading enterprise that integrates R&D, production, and sales for surgical stapler products and energy-based surgical products. The company primarily focuses on the field of minimally invasive surgery. It boasts a 21,000-square-meter intelligent manufacturing center, along with advanced facilities such as 100,000-class and 10,000-class cleanrooms, and an EO sterilization station. Its product portfolio covers four major series: open staplers, endoscopic staplers, ultrasonic systems, and electrosurgical systems. Its sales network covers over 2,000 hospitals across China.

All products have obtained NMPA and EU CE certifications, with some also receiving FDA approval. The company currently holds 177 valid patents and 65 overseas issued patents. Its self-designed ENDO III series endoscopic stapler is the first domestic brand to enter the European market. The company’s self-developed next-generation powered endoscopic stapler has been promoted and applied in 29 provinces across China. It is also exported to over 30 countries, including Brazil, South Korea, France, and Germany.

Reach Surgical has received numerous honors, including National High-tech Enterprise, National-level Specialized and Innovative “Little Giant” Enterprise, Tianjin Manufacturing Single-product Champion Enterprise, and Tianjin Technology Leadership Enterprise. It has been recognized as a Tianjin Enterprise Technology Center and a Tianjin Minimally Invasive Surgical Instrument Technology Engineering Center. 

Disposable Powered Endoscopic Linear Cutting Stapler and Cartridge (iReach Magnum)

The “iReach Magnum”, a new-generation powered stapler self-developed by Reach Surgical, features an innovative disposable blade design in its cartridge. This product is primarily applied for tissue dissection, resection, and anastomosis in open or minimally invasive surgeries in general surgery, gynecology, urology, and thoracic surgery. It can also be applied for the resection and transection of liver tissue. Currently, the product is used in over 2,000 hospitals across 30 provinces in China and has sold over a million units globally.

Ener Reach OP9 Generator and OSA Advanced Bipolar Vessel Sealer

On August 2024, Ener Reach OP9 Generator and OSA Advanced Bipolar Vessel Sealer self-developed by Reach Surgical received CE and NMPA approvals, respectively. The Ener Reach OP9 Generator can output both ultrasonic and electrosurgical energy, which is the world's first integrated energy platform with dual interfaces capable of achieving 7mm vessel sealing. The innovative designs such as intelligent algorithms control meet the needs of various surgeries in general surgery, thoracic surgery, gynecology, urology, and other departments.